Quotient Therapeutics News and Activities

View the org chart displaying its 11 main executives

Most searched biographies at Quotient Therapeutics

• Rahul Kakkar, Chief Executive Officer
• Mike Stratton, Director
• Jacob Rubens, Director

Popular executive movements at Quotient Therapeutics

• Susan Keefe has joined the company as Chief Financial Officer  (posted on February 3 2026).
• Andrew Bayliffe has joined the company as Chief Development Officer  (posted on October 1 2025).

Create your alert
to follow the executive moves at Quotient Therapeutics.

Quotient Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Quotient Therapeutics

• Quotient Therapeutics Appoints Sir Mene Pangalos, Ph.D. to Board of…
• Blog | Quotient news and media
• Flagship Pioneering and Quotient Therapeutics Announce Agreement to…
• Quotient Therapeutics Appoints Peter Campbell, Ph.D. as Chief…
• Media | Quotient news and media
• Flagship Pioneering Unveils Quotient Therapeutics to Create…
• Press | Quotient news and media
• Quotient news and media
• View more press releases Close

Social media about Quotient Therapeutics

• Quotient Therapeutics on Wikipedia, Google News & Yahoo Finance
• Quotient Therapeutics on LinkedIn, X (Twitter) & YouTube